Ludovic Bigot
7PUBLICATIONS
151CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (7)
Sort by Publication Date:
|Feb 03, 2026
Recurrent Resistance Mutations to Lirafugratinib Inform Treatment Sequencing in FGFR2-Driven Tumors.Francesco Facchinetti, Antoine Hollebecque, Rémy Barbé
|Sep 24, 2025
PRT3789 Is a First-in-Human SMARCA2-Selective Degrader That Induces Synthetic Lethality in SMARCA4-Mutated Cancers.Michael Hulse, Min Wang, Chaoyi Xu
|Sep 13, 2024
NVL-655 Is a Selective and Brain-Penetrant Inhibitor of Diverse ALK-Mutant Oncoproteins, Including Lorlatinib-Resistant Compound Mutations.Jessica J Lin, Joshua C Horan, Anupong Tangpeerachaikul
|Sep 03, 2024
Understanding and Overcoming Resistance to Selective FGFR Inhibitors across FGFR2-Driven Malignancies.Francesco Facchinetti, Yohann Loriot, Floriane Brayé
|Apr 17, 2024
Overcoming Osimertinib Resistance with AKT Inhibition in EGFRm-Driven Non-Small Cell Lung Cancer with PIK3CA/PTEN Alterations.Ursula Grazini, Aleksandra Markovets, Lucy Ireland
|Jun 28, 2023
Resistance to Selective FGFR Inhibitors in FGFR-Driven Urothelial Cancer.Francesco Facchinetti, Antoine Hollebecque, Floriane Braye
Pageof 2
Frequent Collaborators
6 joint publications
Luc Friboulet
4 joint publications
Benjamin Besse
4 joint publications
Yohann Loriot
4 joint publications
Catline Nobre
4 joint publications
Lambros Tselikas
3 joint publications
Fabrice André
3 joint publications
Antoine Hollebecque
3 joint publications
Francesco Facchinetti
3 joint publications
Stefan Michiels
3 joint publications
Santiago Ponce-Aix
